The key innovation here is a stable form of psilocin that, when taken ... to be more stable and easier to dose than traditional psilocybin. By modifying the chemical structure, these compounds ...
Psilocin is the active agent of psilocybin. TRP-8803, Tryp’s lead asset is an innovative and scalable psilocin-based IV-infusion formulation with neuroplastic benefits. Neuroplasticity is the ...
The study identified optimal doses and infusion rates that maintained psilocin blood levels within ... outperforming oral psilocybin formulations in terms of consistency. Participants experienced ...
He continued, "Conjugated Psilocin™ is a stable form of psilocin, the active metabolite of psilocybin with attractive pharmacokinetics including rapid and reproducible absorption. Both these ...